Hosted on MSN1mon
Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug(Bloomberg) -- Amgen Inc.’s disclosed that US regulators paused the study of an early-stage obesity drug, a lucrative market the company is trying to crack. The Thousand Oaks, California-based ...
Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre in Hyderabad. The company will inject an initial investment of $200 ...
HYDERABAD, India (Reuters) - U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert Bradway said ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results